CELG-RI Stock Price, Chart, Stats & News
Bristol-Myers Squibb Company Ce (CELG-RI) is a dividend-paying stock with a current dividend yield of 0.00% as of Jul 13, 2026. It pays $0 per share over the trailing twelve months.
CELG-RI chart
Fundamentals
Gross margin | 65.89% |
Operating margin | 31.36% |
Pretax margin | 19.36% |
Net margin | 14.64% |
Effective tax rate | 24.36% |
ROA | 7.83% |
ROE | 39.27% |
D/E | 2.65x |
Interest coverage ratio | 7.99x |
CELG-RI valuation
P/E | – |
P/S | 0.00x |
P/B | 0.01x |
P/CF | 0.01x |
P/FCF | 0.02x |
P/OCF | 0.01x |
PEG | 0.00x |
EV multiple | -2.26x |
About
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
Similar securities
Based on sector and market capitalization
